JNK3 Maintains Expression of the Insulin Receptor Substrate 2 (IRS2) in Insulin-Secreting Cells: Functional Consequences for Insulin Signaling
Saida Abdelli(University Hospital of Lausanne), Christophe Bonny(University Hospital of Lausanne)
Cited by 28
Related Papers
Cell-Permeable Peptide Inhibitors of JNK
|Diabetes|2001|570